Abstract
Objective
The aim of the study was to perform a systematic literature search and meta-analysis to reveal the most effective mouthwash for head and neck cancer patients who are experiencing radiation therapy-induced mucositis.
Methods
Using two electronic databases, a literature search and data interpretation were systematically performed as follows: (i) problem specification, (ii) devising of a literature search plan, (iii) literature search and retrieval of publications, and (iv) meta-analysis and data interpretation. The main problem was specified as follows: what mouthwash is effective in alleviating oral mucositis for head and neck cancer patients who are undergoing radiotherapy?
Results
The literature search yielded 354 titles and abstracts. After reviewing the extracted literature, 25 publications met the inclusion criteria for this study and 17 of 25 were eventually evaluated in the meta-analysis.
Conclusion
The results of the meta-analysis indicated that the use of a mouthwash that includes anti-inflammatory properties contributes the most to alleviating oral mucositis in patients who are undergoing radiotherapy to treat head and neck cancer.
Similar content being viewed by others
References
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545–602.
Japan Society for Head and Neck Cancer, Cancer Registry Committee. Report of head and neck cancer registry of Japan clinical statistics of registered patients. 2015. http://www.jshnc.umin.ne.jp/pdf/2015syourei_houkoku_1027.pdf. Accessed 3 Aug 2018.
Maria OM, Eliopoulos N, Muanza T. Radiation-induced oral mucositis. Front Oncol. 2017;7:89. https://doi.org/10.3389/fonc.2017.00089.
Nicolatou-Galitis O, Dardoufas K, Markoulatos P, Sotiropoulou-Lontou A, Kyprianou K, Kolitsi G. Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash. J Oral Pathol Med. 2001;30:471–80.
Fowler JF, Lindstrom ML. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys. 1992;23:457–67.
McCloskey SA, Jaqqemauth W, Riqual NR, Hicks WL Jr, Popat SR, Sullivan TL Jr, et al. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck. Am J Clin Oncol. 2009;32:587–91.
Patel UA, Patadia MO, Holloway N, Rosen F. Poor radiotherapy compliance predicts persistent regional disease in advanced head/neck cancer. Laryngoscope. 2009;119:528–33.
Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head and neck malignancies. Int J Radiat Oncol Biol Phys. 2007;68:1110–20.
Lalla RV, Ashbury FD. The MASCC/ISOO mucositis guidelines: dissemination and clinical impact. Support Care Cancer. 2013;21:3161–3.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336–41.
Centre for Reviews and Dissemination. University of York. https://www.york.ac.uk/media/crd/Systematic_Reviews.pdf. Accessed 11 Nov 2014.
Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–6.
The Cochrane Collaboration. Cochrane methods: Bias. https://methods.cochrane.org/bias/resources/cochrane-risk-bias-tool. Accessed 31 Jul 2017.
Cochrane Community. RevMan 5. http://community.cochrane.org/tools/review-production-tools/revman-5. Accessed 31 Jul 2017.
Najafi S, Najafi S, Koujan SE, Manifar S, Kharazifard MJ, Kidi S, et al. Preventive effect of Glycyrrhiza glabra extract on oral mucositis in patients under head and neck radiotherapy: a randomized clinical trial. J Dent. 2017;145:267–74.
Yokota T, Ogawa T, Takahashi S, Okami K, Fujii T, Tanaka K, et al. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study. BMC Cancer. 2017;17(1):314. https://doi.org/10.1186/s12885-017-3295-4.
Rastogi M, Khurana R, Revannasiddaiah S, Jaiswal I, Nanda SS, Gupta P, et al. Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (> 50 Gy) with or without chemotherapy. Support Care Cancer. 2017;25:1439–43.
Wong KH, Kuciejewska A, Sharabiani MTA, Ng-Cheng-Hin B, Hoy S, Hurley T, et al. A randomized controlled trial of Caphosol mouthwash in management of radiation-induced mucositis in head and neck cancer. Radiother Oncol. 2017;122:207–11.
Bonfili P, Gravina GL, Marampon F, Rughetti A, Di Staso M, Dell’Orso L, et al. Oral platelet gel supernatant plus supportive medical treatment versus supportive medical treatment in the management of radiation-induced oral mucositis: a matched explorative active control trial by propensity analysis. 2017;40:336–41.
Ghalayani P, Emami H, Pakravan F, Nasr Isfahani M. Comparison of triamcinolone acetonide mucoadhesive film with licorice mucoadhesive film on radiotherapy-induced oral mucositis: a randomized double-blinded clinical trial. Asia Pac J Clin Oncol. 2017;13:e48–56.
Liang G, Du W, Ke Q, Huang B, Yang J. The effects of recombinant human granulocyte colony-stimulating factor mouthwash on radiotherapy-induced oral mucositis in locally advanced nasopharyngeal carcinoma patients. Adv Clin Exp Med. 2017;26:409–13.
Diaz-Sanchez RM, Pachon-Ibanez J, Marin-Conde F, Rodriguez-Caballero A, Gutierrez-Perez JL, Torres-Lagares D. Double-blind, randomized pilot study of bioadhesive chlorhexidine gel in the prevention and treatment of mucositis induced by chemoradiotherapy of head and neck cancer. Med Oral Pathol Oral Cir Bucal. 2015;20:e378–85.
Sahebjamee M, Mansourian A, Hajimiramonhammad M, Zadeh MY, Bekhradi R, Kazemian A, et al. Comparative efficacy of aloe vera and benzydamine mouthwashes on radiation-induced oral mucositis: a triple-blind, randomized, controlled clinical trial. Oral Health Prev Dent. 2015;13:309–15.
Allison RR, Ambrad AA, Arshoun Y, Carmel RJ, Ciuba DF, Feldman E, et al. Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck. Cancer. 2014;120:1433–40.
Hawley P, Hovan A, McGahan CE, Saunders D. A randomized placebo-controlled trial of manuka honey for radiation-induced oral mucositis. Support Care Cancer. 2014;22:751–61.
Rao S, Dinkar S, Vaishnav LK, Rao P, Rai MP, Fayad R, et al. The Indian spice turmeric delays and mitigates radiation-induced oral mucositis in patients undergoing treatment for head and neck cancer: an investigational study. Integr Cancer Ther. 2014;13:201–10.
Lambrecht M, Mercier C, Geussens Y, Nuyts S. The effect of a supersaturated calcium phosphate mouth rinse on the development of oral mucositis in head and neck cancer patients treated with (chemo)radiation: a single-center, randomized, prospective study of a calcium phosphate mouth rinse + standard of care versus standard of care. Support Care Cancer. 2013;21:2663–70.
Pawar D, Neve RS, Kalgane S, Riva A, Bombardelli E, Ronchi M, et al. SAMITAL® improves chemo/radiotherapy-induced oral mucositis in patients with head and neck cancer: results of a randomized, placebo-controlled, single-blind Phase II study. Support Care Cancer. 2014;22:751–61.
Nakayama M, Fujiwara M, Nakamura T, Azuma T, Matzno S, Kamikonya N, et al. Stability of polaprezinc-containing oral rinse and its clinical effectiveness against radiotherapy-induced oral mucositis. Jpn J Drug Inform. 2013;15:133–8.
Yen SH, Wang LW, Lin YH, Jen YM, Chung YL. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2012;82:1463–70.
Sharma A, Rath GK, Chaudhary SP, Thakar A, Mohanti BK, Bahadur S. Lactobacillus brevis CD2 lozenges reduce radiation and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study. Eur J Cancer. 2012;48:875–81.
Bardy J, Molassiotis A, Ryder WD, Mais K, Sykes A, Yap B, et al. A double-blind, placebo-controlled, randomised trial of active manuka honey and standard oral care for radiation-induced oral mucositis. Br J Oral Maxillofac Surg. 2012;50:221–6.
Tosaka C, Tajima H, Inoue T, Moya M, Kobayashi M, Miura K, et al. Investigation of how to prevent mucositis induced by chemoradiotherapy. Jpn J Cancer Chemother. 2011;38:1647–51 (Japanese)
Satheeshkumar PS, Chamba MS, Balan A, Sreelatha KT, Bhatathiri VN, Bose T. Effectiveness of triclosan in the management of radiation-induced oral mucositis: a randomized clinical trial. J Cancer Res Ther. 2010;6:466–72.
Maddocks-Jennings W, Wilkinson JM, Cavanagh HM, Shillington D. Evaluating the effects of the essential oils Leptospermum scoparium (manuka) and Kunzea ericoides (kanuka) on radiotherapy induced mucositis: a randomized, placebo controlled feasibility study. Eur J Oncol Nurs. 2009;13:87–93.
Madan PD, Sequeira PS, Shenoy K, Shetty J. The effect of three mouthwashes on radiation-induced oral mucositis in patients with head and neck malignancies: a randomized control trial. J Cancer Res Ther. 2008;4:3–8.
Cheng KK, Yuen JKT. A pilot study of chlorhexidine and benzydamine oral rinses for the prevention and treatment of irradiation mucositis in patients with head and neck cancer. Cancer Nurs. 2006;29:423–30.
Naidu MU, Ramana GV, Ratnam SV, Sudhavani T, Naidu KJ, Roy P, et al. A randomised, double-blind, parallel, placebo-controlled study to evaluate the efficacy of MF 5232 (Mucotrol), a concentrated oral gel wafer, in the treatment of oral mucositis. Drugs R D. 2005;6:291–8.
Trotti A, Garden A, Warde P, Symonds P, Langer C, Redman R, et al. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. Int J Radiat Oncol Biol Phys. 2004;58:674–81.
Acknowledgements
The authors thank Dr. Keiji Tanimoto (Professor Emeritus, Hiroshima University) for his help.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Masaru Konishi, Rinus Gerardus Verdonschot, Kiichi Shimabukuro, Takashi Nakamoto, Minoru Fujita, and Naoya Kakimoto declare that they have no conflict of interest.
Human rights statements
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.
Informed consent
Informed consent was obtained from all patients for being included in the study.
Rights and permissions
About this article
Cite this article
Konishi, M., Verdonschot, R.G., Shimabukuro, K. et al. The effectiveness of mouthwashes in alleviating radiation-induced oral mucositis in head and neck cancer patients: a systematic review. Oral Radiol 35, 207–223 (2019). https://doi.org/10.1007/s11282-018-0361-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11282-018-0361-9